Langues

Management Team

iStock_13956762XSmall

Neurolixis benefits from a management team with many decades of cumulative industrial and academic experience. The members of the team bring drug discovery, neuropharmacology, clinical research and company management expertise to Neurolixis.

 

Mark A. Varney, PhD, Co-founder, President and Chief Executive Officer

Dr. Varney has spent over two decades in pharmaceutical research and was previously Chief Executive Officer of Cortex Pharmaceuticals, and Vice-President and Head of Discovery at Sepracor (now Sunovion). More...

 

Adrian Newman-Tancredi, PhD, DSc Co-founder and Chief Scientific Officer

Dr. Newman-Tancredi has broad expertise in neuroscience drug discovery and early pre-clinical development. He was previously Director of Neurobiology and Project Manager at Pierre Fabre Laboratories. More...

 

Steven A. Johnson, PhD, Vice-President, Drug Development

Dr. Johnson has extensive experience of pre-clinical and clinical drug development in neurobiology and neuropsychiatry. He was previously Vice-President and Executive Officer at Cortex Pharmaceuticals. More...